PROSTATE cancer patients with weeks or months left to live could survive longer after undergoing immunotherapy treatment, a major trial has shown. More than a third of men with a very advanced form of the cancer were still alive, and one in 10 had not seen the cancer grow, after a year on the drug pembrolizumab, the study found.
from Daily Express :: Health Feed http://bit.ly/2J7lB93
via Buy Breast Actives
from Tumblr http://bit.ly/2kQ6vWR
No comments:
Post a Comment